APOE and wet macular degeneration: A study that included 192 nvAMD (Neovascular age related macular degeneration) patients who received anti-VEGF treatment found that the APOE ε4 allele was significantly associated with significant visual improvement compared to APOE alleles at 3,6 and 12 month after treatment initiation [94].